COLORADO DENVER UNIVERSITY OF

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

A Double-blind, Placebo Controlled Trial of Risperidone for the Treatment of Anorexia Nervosa

Phase 4

Completed

Conditions: Anorexia Nervosa

Interventions: Drug: Placebo
Drug: Risperidone

First Posted Date: 2005-09-01

Last Posted Date: 2016-02-02

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 41

Registration Number: NCT00140426

Locations: 🇺🇸
The Children's Hospital, Denver, Colorado, United States

TEAM: Testosterone Supplementation and Exercise in Elderly Men

Phase 2

Completed

Conditions: Healthy

Interventions: Drug: LowT
Behavioral: Resistance Training
Drug: HighT
Drug: Placebo

First Posted Date: 2005-05-30

Last Posted Date: 2020-09-02

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 167

Registration Number: NCT00112151

Locations: 🇺🇸
University of Colorado Health Sciences Center, Denver, Colorado, United States

Sputum Cytology in Screening Heavy Smokers For Lung Cancer

Phase 2

Completed

Conditions: Lung Cancer

First Posted Date: 2005-02-08

Last Posted Date: 2014-05-07

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 3270

Registration Number: NCT00103363

Locations: 🇺🇸
University of Colorado Health Sciences Center - Denver, Denver, Colorado, United States

HIV and HCV Intervention In Drug Treatment Settings - 1

Phase 3

Completed

Conditions: Behavior Therapy

First Posted Date: 2005-01-28

Last Posted Date: 2017-01-12

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 706

Registration Number: NCT00102349

Locations: 🇺🇸
Island Grove RTC, Greeley, Colorado, United States
🇺🇸
SSTAR of Rhode Island - North Kingstown, North Kingstown, Rhode Island, United States
🇺🇸
Recovery Center King Co.-Kent Detox, Kent, Washington, United States

and more 5 locations

Improving Prevention of Heart Disease in Latinos

Completed

Conditions: Diabetes Mellitus
Cardiovascular Diseases
Heart Diseases
Hypertension

First Posted Date: 2005-01-11

Last Posted Date: 2015-10-01

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 179

Registration Number: NCT00101530

Locations: 🇺🇸
Denver Health Medical Center, Denver, Colorado, United States

Phase 2 Trial of a Nicotinic Agonist in Schizophrenia

Phase 2

Completed

Conditions: Schizophrenia

Interventions: Drug: Placebo
Drug: 3-(2,4 dimethoxybenzylidene anabaseine) 150 mg
Drug: 3-(2,4 dimethoxybenzylidene anabaseine) 75 mg

First Posted Date: 2004-12-24

Last Posted Date: 2020-01-29

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 29

Registration Number: NCT00100165

Locations: 🇺🇸
VA Eastern Colorado Health Care System, Denver, CO, Denver, Colorado, United States

Cryosurgery in Treating Patients With Liver Cancer or Liver Metastases

Phase 2

Completed

Conditions: Liver Cancer
Metastatic Cancer

First Posted Date: 2004-08-11

Last Posted Date: 2013-07-22

Lead Sponsor: University of Colorado, Denver

Registration Number: NCT00002655

Locations: 🇺🇸
University of Colorado Cancer Center, Denver, Colorado, United States

Cytotoxic T Cells and Interleukin-2 in Treating Adult Patients With Recurrent Brain Tumors

Phase 1

Completed

Conditions: Brain and Central Nervous System Tumors

First Posted Date: 2004-07-29

Last Posted Date: 2013-05-30

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 10

Registration Number: NCT00002572

Locations: 🇺🇸
University of Colorado Cancer Center, Denver, Colorado, United States
🇺🇸
Children's Health Center, Denver, Colorado, United States
🇺🇸
Veterans Affairs Medical Center - Denver, Denver, Colorado, United States

Irofulven in Treating Patients With Stage IV Melanoma

Phase 2

Completed

Conditions: Melanoma (Skin)

First Posted Date: 2004-06-21

Last Posted Date: 2013-05-30

Lead Sponsor: University of Colorado, Denver

Registration Number: NCT00005968

Locations: 🇺🇸
John Wayne Cancer Institute, Santa Monica, California, United States
🇺🇸
Ellis Fischel Cancer Center - Columbia, Columbia, Missouri, United States
🇺🇸
University of Colorado Cancer Center, Denver, Colorado, United States

and more 2 locations

Iloprost in Preventing Lung Cancer in Patients at High Risk for This Disease

Phase 2

Completed

Conditions: Lung Cancer
Precancerous Condition

Interventions: Other: placebo
Drug: iloprost

First Posted Date: 2004-06-11

Last Posted Date: 2020-05-14

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 152

Registration Number: NCT00084409

Locations: 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
🇺🇸
Mayo Clinic Cancer Center, Rochester, Minnesota, United States
🇺🇸
University of Colorado Cancer Center at UC Health Sciences Center, Aurora, Colorado, United States

and more 3 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy